Facial Injectable

Facial Injectable Market Outlook

The global facial injectable market is projected to reach approximately USD 15.2 billion by 2035, expanding at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2035. This growth can be attributed to the increasing demand for non-invasive cosmetic procedures, driven by a growing awareness of aesthetic treatments among consumers. Additionally, the rising geriatric population seeking facial rejuvenation treatments and advancements in injection technologies are further fueling the market growth. The influence of social media and celebrity endorsements promoting facial injectables has also significantly impacted consumer interest. Furthermore, the expanding availability of a wide array of products, tailored to meet diverse consumer preferences, will likely contribute to the market's upward trajectory.

Growth Factor of the Market

One of the primary growth factors for the facial injectable market is the increasing acceptance of aesthetic procedures across various demographics. As more individuals prioritize their appearance, especially influenced by social media, the demand for facial injectables has surged. Additionally, the development of new and innovative products, such as longer-lasting fillers and those with improved safety profiles, has opened new opportunities for practitioners and consumers alike. The growing trend of preventive treatments, where younger individuals opt for injectables to prevent signs of aging, is also contributing to market expansion. Moreover, the rise in disposable income and changing lifestyle patterns are enabling more consumers to seek these cosmetic enhancements. Lastly, educational initiatives by industry professionals have heightened awareness about the benefits and safety of facial injectables, further propelling market growth.

Key Highlights of the Market

• Rapid advancements in injectable technologies are enhancing safety and efficacy.
• Growing popularity of non-surgical procedures due to minimal downtime.
• Increase in social media influence driving consumer interest in aesthetic treatments.
• Expansion of distribution channels, including online platforms for easier access.
• Rising demand for customized solutions catering to individual preferences.

By Product Type

Dermal Fillers:

Dermal fillers account for a significant portion of the facial injectable market, primarily due to their versatility and effectiveness in restoring volume and fullness to facial features. They are commonly used in areas such as cheeks, lips, and nasolabial folds. Composed of substances like hyaluronic acid, these fillers can hydrate the skin and provide a youthful appearance. The rapid expansion of the aesthetic market has led to increased consumer awareness about the benefits of dermal fillers, driving their popularity. Furthermore, the availability of various formulations allows practitioners to customize treatments based on individual needs, enhancing patient satisfaction and outcomes.

Anti-Wrinkle Injections:

Anti-wrinkle injections, primarily composed of botulinum toxin, represent another substantial segment of the facial injectable market. These injections work by temporarily paralyzing muscles, thereby reducing the appearance of fine lines and wrinkles, particularly around the eyes and forehead. The increasing adoption of these treatments among both younger and older populations is evident as individuals seek to maintain a youthful appearance. Safety and efficacy continue to be driving forces, as medical professionals increasingly utilize these injections in their practice. Ongoing research into the long-term effects and potential therapeutic applications of these products further fuels market growth.

Collagen Stimulators:

Collagen stimulators are gaining traction in the facial injectable market as they promote natural collagen production, leading to longer-lasting results compared to traditional fillers. These products typically contain poly-L-lactic acid or calcium hydroxylapatite, which stimulate the body’s natural regenerative processes. Patients seeking more permanent solutions for volume loss and skin texture improvements are turning to collagen stimulators. Their growing popularity is supported by endorsements from dermatologists and cosmetic surgeons, who appreciate the natural-looking results they can achieve with these injectables. As consumer knowledge about the benefits of collagen stimulation rises, this segment is poised for significant growth.

Biodegradable Implants:

Biodegradable implants are a niche yet emerging segment of the facial injectable market, appealing to consumers seeking sustainable and temporary solutions for aesthetic enhancements. These implants gradually dissolve in the body, providing a temporary effect that can be appealing to those hesitant about long-term commitments. The rise in eco-conscious consumerism has led to increased interest in biodegradable options, particularly among younger demographics. Additionally, advancements in material science and technology are enhancing the safety and efficacy of these products, making them an attractive option for practitioners and patients alike.

Polymers:

Polymers as a product type in the facial injectable market represent a unique category that combines the benefits of stability and adaptability. These materials can be utilized in various formulations to achieve different textures and durations of effect. The versatility of polymers allows them to be tailored for specific facial areas, enhancing the overall patient experience. As research progresses, more innovative polymer-based injectables are expected to enter the market, offering new solutions for consumers seeking effective aesthetic enhancements. This segment is likely to grow in popularity due to advancements in technology and increased consumer demand for custom solutions.

Others:

This category encompasses a variety of injectable products that do not fall into the standard classifications. These may include newer formulations and experimental products that are still undergoing clinical trials. As technology and research evolve, this segment has the potential to expand significantly, offering patients more options for personalized aesthetic treatments. The growth of this segment will largely depend on regulatory approvals and clinical validations, but it represents an exciting frontier in the facial injectable market.

By Application

Facial Line Correction:

Facial line correction is one of the most common applications of facial injectables, focusing on reducing the appearance of wrinkles and fine lines. This application has gained immense popularity due to the aging population and increasing beauty consciousness among younger individuals. Practitioners often utilize a combination of dermal fillers and anti-wrinkle injections to achieve optimal results, providing a comprehensive approach to facial rejuvenation. Advances in technologies, such as micro-cannula techniques, allow for more precise application, leading to safer and more effective treatments. As patient awareness of available options grows, this application segment is expected to witness continued growth.

Lip Augmentation:

Lip augmentation has become a highly sought-after procedure, particularly among younger demographics looking to achieve fuller, more defined lips. Dermal fillers specifically designed for lip enhancement offer a minimally invasive solution with instant results. The influence of social media and celebrity culture has propelled the popularity of lip fillers, making them a staple in the aesthetic treatment arsenal. With various product options available, practitioners can customize lip augmentation treatments to meet individual preferences, further driving demand in this application area. The rise in promotional campaigns targeting lip enhancement has also contributed to its significant market growth.

Facial Volume Restoration:

Facial volume restoration is critical in combating the effects of aging, as volume loss leads to sagging skin and a tired appearance. This application utilizes a variety of injectables, including dermal fillers and collagen stimulators, to restore youthful contours. Increased knowledge about the aging process and the natural effects of gravity has encouraged more individuals to seek volume restoration solutions. Additionally, the versatility of injectables allows for targeted treatments in various areas, such as cheeks, temples, and jawlines, catering to diverse patient needs. As technology and techniques continue to advance, this application segment is expected to flourish.

Others:

The 'Others' category encompasses various applications of facial injectables that do not directly align with the primary categories. This may include off-label uses or innovative applications being explored in clinical settings. As the field of aesthetic medicine evolves, practitioners are increasingly experimenting with injectables to address specific patient concerns, such as scars, skin irregularities, or even medical conditions. The growth of this segment will depend on ongoing research and emerging trends, but it highlights the adaptability of facial injectables in meeting the evolving needs of patients.

By Distribution Channel

Hospitals:

Hospitals play a crucial role in the distribution of facial injectables, particularly in the context of advanced and specialized treatment options. Many hospitals have dedicated dermatology or plastic surgery departments where trained professionals administer injectable treatments. The presence of board-certified specialists in these settings allows for a higher level of care and safety, attracting patients seeking reliable aesthetic solutions. Furthermore, hospitals often collaborate with reputable product manufacturers, ensuring access to high-quality injectables. As more hospitals expand their aesthetic offerings, this distribution channel is expected to grow significantly, catering to an increasing patient population.

Dermatology Clinics:

Dermatology clinics serve as a primary distribution channel for facial injectables, providing specialized care tailored to skin health and aesthetics. These clinics typically employ experienced dermatologists who understand the nuances of facial anatomy and can provide personalized treatment plans for their patients. The dedicated focus on skin-related issues enhances the quality of care, leading to improved outcomes and satisfied clients. As the demand for non-invasive cosmetic procedures continues to rise, dermatology clinics are likely to expand their injectable offerings, further solidifying their position in the market.

Beauty Clinics:

Beauty clinics, often known for their focus on aesthetic treatments, have become increasingly popular as a distribution channel for facial injectables. These establishments offer a range of services, including injectables, skincare treatments, and other non-invasive procedures. The competitive landscape of beauty clinics, characterized by innovative marketing strategies and customer engagement programs, attracts a diverse clientele. Additionally, the rise of minimally invasive treatments, combined with the convenience and accessibility of beauty clinics, has led to a surge in demand for injectables. As more beauty clinics incorporate injectables into their service offerings, this distribution channel is expected to experience robust growth.

Online Stores:

The emergence of online stores as a distribution channel for facial injectables signifies a shift in how consumers access aesthetic products and services. The convenience of online shopping allows patients to research and purchase products from the comfort of their homes, increasing accessibility to a wider audience. E-commerce platforms often provide detailed product information, customer reviews, and educational resources, empowering consumers to make informed decisions. However, the online sale of injectables raises concerns regarding safety and authenticity, prompting regulations and guidelines to ensure consumer protection. As the online market for injectables evolves, it has the potential to become a significant distribution channel in the aesthetic field.

Others:

This category includes various alternative distribution channels for facial injectables that do not fit into the primary classifications. These may encompass mobile services, traveling clinics, or partnerships with wellness centers and spas. As consumer preferences shift towards convenience and personalized care, such alternative channels are becoming increasingly relevant. Innovative service delivery models, including at-home injectables administered by licensed professionals, are gaining traction among consumers seeking flexibility. This segment is expected to grow as the aesthetic industry continues to adapt to changing consumer demands and lifestyles.

By Ingredient Type

Hyaluronic Acid:

Hyaluronic acid is one of the most widely used ingredient types in the facial injectable market due to its biocompatibility and ability to retain moisture. As a naturally occurring substance in the body, hyaluronic acid provides hydration and volume, making it ideal for various applications, including lip augmentation and wrinkle reduction. The versatile nature of hyaluronic acid fillers allows for different formulations, catering to a range of treatment areas and patient preferences. Moreover, the demand for non-surgical, minimally invasive procedures has propelled hyaluronic acid fillers to the forefront of the aesthetic market, leading to continuous product innovation and development.

Calcium Hydroxylapatite:

Calcium hydroxylapatite is another significant ingredient type employed in facial injectables, known for its structural support and longevity. This mineral-like compound is primarily used for deeper lines and volume restoration, offering long-lasting results compared to other fillers. Its natural composition allows for gradual integration into the skin, stimulating collagen production over time. The growing popularity of calcium hydroxylapatite injectables is driven by patient satisfaction and the desire for more permanent solutions in aesthetic treatments. As awareness of this ingredient type increases, its market presence is expected to expand alongside ongoing advancements in formulation techniques.

Poly-L-lactic Acid:

Poly-L-lactic acid is a synthetic biodegradable substance that acts as a collagen stimulator, making it effective for facial volume restoration. Unlike traditional fillers that provide immediate results, poly-L-lactic acid stimulates the body’s natural collagen production over time, leading to gradual and natural-looking improvements. This unique mechanism appeals to patients seeking longer-lasting effects without the need for frequent re-treatments. The demand for poly-L-lactic acid injectables has been rising, particularly among individuals who prioritize subtle and natural enhancements. As practitioners become more familiar with its benefits, this ingredient type is poised for growth in the cosmetic market.

Polymethyl-Methacrylate Microspheres:

Polymethyl-methacrylate microspheres are a more permanent solution in the realm of facial injectables, providing a unique alternative to traditional fillers. These microspheres act as a scaffold for collagen production, resulting in long-lasting volume retention. Though they require a more invasive procedure for placement compared to temporary fillers, their durability appeals to patients seeking lasting results. The growing interest in more permanent solutions for facial augmentation has led to an increase in the adoption of this ingredient type. As safety profiles improve and awareness of their benefits spreads, polymethyl-methacrylate microspheres are expected to gain traction in the market.

Others:

The 'Others' category encompasses various ingredient types utilized in facial injectables that do not fall within the primary classifications. This may include newer formulations and experimental compounds that are currently under research and development. As the field of aesthetic medicine continuously evolves, new ingredient types are being explored to enhance efficacy, safety, and patient satisfaction. This segment represents a promising opportunity for innovation, encouraging manufacturers to invest in research and development to bring novel solutions to market. The growth of this category will largely depend on regulatory approvals and the successful clinical validation of emerging ingredients.

By Region

The facial injectable market exhibits significant geographical variation, with North America dominating the landscape, accounting for over 45% of the global market share. This dominance is attributed to the high disposable income of consumers, a well-established aesthetic industry, and a growing number of skilled practitioners. The increasing demand for non-invasive cosmetic procedures, along with rising awareness and acceptance of facial injectables, has fueled growth in this region. The CAGR for North America is expected to exceed 10.5% between 2025 and 2035, driven by innovative product launches and a surge in consumer interest. Moreover, social media's influence in promoting aesthetic treatments contributes to the growing demand in this region.

Europe follows closely behind, holding a substantial share of the facial injectable market, driven by a robust aesthetic culture and increasing consumer interest in cosmetic procedures. Countries like Germany, France, and the United Kingdom are at the forefront of this growth, with an expanding base of practitioners and clinics offering diverse injectable options. The increasing acceptance of aesthetic treatments among the older population, coupled with the rise of beauty-focused social media influences, is propelling demand in this region. Additionally, advancements in product formulation and technology are enhancing the safety and efficacy of facial injectables, further driving growth in the European market.

Opportunities

The facial injectable market presents a multitude of opportunities for growth, particularly as consumer preferences evolve toward more natural and long-lasting results. One significant opportunity lies in the development of innovative formulations that enhance product efficacy and safety. As research progresses, new ingredients and technologies can be introduced, offering practitioners and patients advanced options tailored to their specific needs. Furthermore, the growing trend of preventive aesthetics, where younger demographics seek injectables to maintain their appearance, opens a new avenue for market expansion. Educational initiatives aimed at promoting awareness about the benefits and safety of injections can help demystify these treatments, driving further engagement among potential consumers.

Another key opportunity is the expansion of distribution channels, particularly the increasing prevalence of online platforms. As e-commerce continues to grow, there is potential for facial injectables to become more accessible to a broader audience. This includes not only consumer education on available options but also the convenience of purchasing products through reputable online stores. In addition, the integration of technology, such as virtual consultations and augmented reality tools, can enhance the patient experience and streamline the process of selecting appropriate treatments. By leveraging these opportunities, stakeholders in the facial injectable market can position themselves for sustained growth and success.

Threats

The facial injectable market faces significant threats, primarily stemming from the increasing incidence of counterfeit products and unregulated practices. As demand for aesthetic procedures grows, so does the risk of illicit providers offering substandard or dangerous injectables. This not only jeopardizes patient safety but can also tarnish the reputation of legitimate practitioners and the industry at large. Regulatory bodies are intensifying their efforts to combat these threats, but the prevalence of counterfeit products remains a concern that must be addressed to protect consumers and maintain confidence in the market.

Moreover, as the market becomes increasingly competitive, price wars may emerge among manufacturers and practitioners, leading to potential reductions in profit margins. The influx of new entrants and alternative aesthetic treatments may further exacerbate this challenge, forcing established players to differentiate themselves through innovative products and superior service offerings. Additionally, economic downturns may influence consumer spending on discretionary aesthetic treatments, affecting overall market growth. Stakeholders need to navigate these threats strategically to maintain market stability and ensure long-term success.

Competitor Outlook

• Allergan Aesthetics (AbbVie Inc.)
• Revance Therapeutics, Inc.
• Galderma S.A.
• Medytox, Inc.
• Hugel, Inc.
• Hyaluronic Acid
• Ipsen S.A.
• Revance Therapeutics, Inc.
• Merz Pharmaceuticals GmbH
• Prollenium Medical Technologies Inc.
• Alastin Skincare
• PDO Thread
• Croma Pharma GmbH
• Sciton, Inc.
• IBSA Farmaceutici Italia Srl

In the competitive landscape of the facial injectable market, numerous well-established and emerging companies vie for market share. Major players such as Allergan Aesthetics (AbbVie Inc.) hold a significant portion of the market with their flagship products like Juvederm, which are recognized for their quality and effectiveness. Galderma S.A., another prominent company, offers the Restylane product line, catering to a diverse range of facial injectable needs. These companies leverage extensive marketing strategies and robust distribution networks to maintain their market positions, ensuring their products remain accessible to consumers and practitioners alike. Additionally, continuous investment in research and development allows these companies to innovate and introduce new products, further strengthening their competitive edge.

Emerging companies, such as Revance Therapeutics, are also making waves in the market with groundbreaking technologies and formulations, such as their DaxibotulinumtoxinA injection. With a focus on long-lasting results and reduced downtime, their products appeal to modern consumers seeking effective aesthetic solutions. Other contenders like Merz Pharmaceuticals and Medytox are also expanding their offerings, introducing new injectables that emphasize safety and efficacy. As the market landscape becomes increasingly dynamic, it will be crucial for both established players and newcomers to adapt to changing consumer demands and regulatory environments, ensuring they remain competitive in this evolving field.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ipsen S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 PDO Thread
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hugel, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sciton, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Galderma S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Medytox, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Hyaluronic Acid
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Alastin Skincare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Croma Pharma GmbH
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Merz Pharmaceuticals GmbH
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Revance Therapeutics, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 IBSA Farmaceutici Italia Srl
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Allergan Aesthetics (AbbVie Inc.)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Prollenium Medical Technologies Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Facial Injectable Market, By Application
    • 6.1.1 Facial Line Correction
    • 6.1.2 Lip Augmentation
    • 6.1.3 Facial Volume Restoration
    • 6.1.4 Others
  • 6.2 Facial Injectable Market, By Product Type
    • 6.2.1 Dermal Fillers
    • 6.2.2 Anti-Wrinkle Injections
    • 6.2.3 Collagen Stimulators
    • 6.2.4 Biodegradable Implants
    • 6.2.5 Polymers
    • 6.2.6 Others
  • 6.3 Facial Injectable Market, By Ingredient Type
    • 6.3.1 Hyaluronic Acid
    • 6.3.2 Calcium Hydroxylapatite
    • 6.3.3 Poly-L-lactic Acid
    • 6.3.4 Polymethyl-Methacrylate Microspheres
    • 6.3.5 Others
  • 6.4 Facial Injectable Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Dermatology Clinics
    • 6.4.3 Beauty Clinics
    • 6.4.4 Online Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Facial Injectable Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Facial Injectable market is categorized based on

By Product Type

• Dermal Fillers
• Anti-Wrinkle Injections
• Collagen Stimulators
• Biodegradable Implants
• Polymers
• Others

By Application

• Facial Line Correction
• Lip Augmentation
• Facial Volume Restoration
• Others

By Distribution Channel

• Hospitals
• Dermatology Clinics
• Beauty Clinics
• Online Stores
• Others

By Ingredient Type

• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• Polymethyl-Methacrylate Microspheres
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Allergan Aesthetics (AbbVie Inc.)
• Revance Therapeutics, Inc.
• Galderma S.A.
• Medytox, Inc.
• Hugel, Inc.
• Hyaluronic Acid
• Ipsen S.A.
• Revance Therapeutics, Inc.
• Merz Pharmaceuticals GmbH
• Prollenium Medical Technologies Inc.
• Alastin Skincare
• PDO Thread
• Croma Pharma GmbH
• Sciton, Inc.
• IBSA Farmaceutici Italia Srl